Manufacturer Intelligence · Based on 130,418 FDA 510(k) records · 83 countries

FDA 510(k) Medical Device Manufacturers - Norway

Norwegian medical device manufacturers ranked by FDA 510(k) submission volume. This is not a curated directory - rankings reflect real submission activity extracted from FDA accessdata.gov records.

  • Compare manufacturers by FDA 510(k) submission activity
  • Identify clearance rates, active panels and years of FDA activity
  • Filter by country or FDA review panel specialty
15
Manufacturers
Norway
Country

Norway FDA 510(k) Overview

15
Manufacturers
38
Submissions
100%
Clearance rate

Leading Norway FDA 510(k) manufacturers include Ge Vingmed Ultrasound AS, Nordicneurolab AS, Laerdal Medical AS and 12 others.

Norwegian medical device manufacturers have submitted 38 FDA 510(k) notifications since 1996, achieving a 100% clearance rate across 15 manufacturers. Norway's medtech sector shows specialization in cardiovascular monitoring, point-of-care diagnostics and digital health solutions, reflecting the country's advanced healthcare system and technology innovation capacity.

Active in FDA 510(k) submissions since 1996. Many Norway manufacturers work with FDA regulatory consultants to support U.S. market entry.

FDA 510(k) Norway Manufacturers

1–15 of 15
# Manufacturer Submissions Cleared Active panels Country
1 7 100%
RA
NO
2 7 100%
RA
NO
3 5 100%
AN CV
NO
4 3 100%
AN CV SU
NO
5 3 100%
CH
NO
6 2 100%
RA
NO
7 2 100%
HO
NO
8 2 100%
NE
NO
9 1 100%
HO
NO
10 1 100%
RA
NO
11 1 100%
CH
NO
12 1 100%
SU
NO
13 1 100%
CV
NO
14
Excitus AS
Stavanger
1 100%
SU
NO
15 1 100%
RA
NO

About This FDA 510(k) Manufacturer Database

Data Source and Methodology

Rankings are based on the total number of published FDA 510(k) submissions per manufacturer in the 510k Database dataset, derived from FDA 510(k) public files. This is not a curated or paid listing - manufacturer rankings reflect real regulatory activity.

Used by regulatory affairs teams and medtech consultants to benchmark manufacturer activity, identify predicate device candidates, and analyze competitive positioning across FDA review panels.